皮肤癌中的表观遗传生物标志物。
Epigenetic biomarkers in skin cancer.
机构信息
Department of Molecular Oncology, John Wayne Cancer Institute at Saint John's Health Center, Santa Monica, CA, USA.
出版信息
Cancer Lett. 2014 Jan 28;342(2):170-7. doi: 10.1016/j.canlet.2012.01.020. Epub 2012 Jan 27.
Abstract
Epigenetic aberrations have been associated with cutaneous melanoma tumorigenesis and progression including dysregulated DNA gene promoter region methylation, histone modification, and microRNA. Several of these major epigenetic aberrations have been developed into biomarkers. Epigenetic biomarkers can be detected in tissue and in blood as circulating DNA in melanoma patients. There is strong evidence that biomarkers in cutaneous melanoma will have an important role as companions to therapeutics and overall patient management. Important progress has been made in epigenetic melanoma biomarker development and verification of clinical utility, and this review discusses some of the key current developments and existing challenges.
摘要
表观遗传异常与皮肤黑色素瘤的发生和发展有关，包括 DNA 基因启动子区域的异常甲基化、组蛋白修饰和 microRNA。其中一些主要的表观遗传异常已被开发成为生物标志物。在黑色素瘤患者的组织和血液中，如循环 DNA 中，可以检测到这些表观遗传生物标志物。有强有力的证据表明，皮肤黑色素瘤的生物标志物将作为治疗和整体患者管理的辅助手段发挥重要作用。在表观遗传黑色素瘤生物标志物的开发和临床实用性验证方面已经取得了重要进展，本综述讨论了一些当前的关键进展和存在的挑战。
相似文献
1
Epigenetic biomarkers in skin cancer.皮肤癌中的表观遗传生物标志物。
Cancer Lett. 2014 Jan 28;342(2):170-7. doi: 10.1016/j.canlet.2012.01.020. Epub 2012 Jan 27.
2
Epigenetics of cutaneous T-cell lymphoma: biomarkers and therapeutic potentials.皮肤 T 细胞淋巴瘤的表观遗传学：生物标志物和治疗潜力。
Cancer Biol Med. 2021 Feb 15;18(1):34-51. doi: 10.20892/j.issn.2095-3941.2020.0216.
3
CpG island methylator phenotype predicts progression of malignant melanoma.CpG岛甲基化表型可预测恶性黑色素瘤的进展。
Clin Cancer Res. 2009 Mar 1;15(5):1801-7. doi: 10.1158/1078-0432.CCR-08-1361. Epub 2009 Feb 17.
4
Downregulation of microRNA-29c is associated with hypermethylation of tumor-related genes and disease outcome in cutaneous melanoma.microRNA-29c 的下调与皮肤黑色素瘤中肿瘤相关基因的高甲基化和疾病结局相关。
Epigenetics. 2011 Mar;6(3):388-94. doi: 10.4161/epi.6.3.14056. Epub 2011 Mar 1.
5
Comprehensive investigation of matrix metalloproteinases in skin cutaneous melanoma: diagnostic, prognostic, and therapeutic insights.皮肤黑色素瘤中基质金属蛋白酶的综合研究：诊断、预后及治疗见解
Sci Rep. 2025 Jan 16;15(1):2152. doi: 10.1038/s41598-025-85887-2.
6
Melanoma epigenetics: novel mechanisms, markers, and medicines.黑色素瘤表观遗传学：新机制、标志物和药物。
Lab Invest. 2014 Aug;94(8):822-38. doi: 10.1038/labinvest.2014.87. Epub 2014 Jun 30.
7
Epigenetic regulation in human melanoma: past and future.人类黑色素瘤中的表观遗传调控：过去与未来
Epigenetics. 2015;10(2):103-21. doi: 10.1080/15592294.2014.1003746.
8
AIM1 and LINE-1 epigenetic aberrations in tumor and serum relate to melanoma progression and disease outcome.AIM1 和 LINE-1 肿瘤和血清中的表观遗传异常与黑色素瘤的进展和疾病结局有关。
J Invest Dermatol. 2012 Jun;132(6):1689-97. doi: 10.1038/jid.2012.36. Epub 2012 Mar 8.
9
DSS1 promoter hypomethylation and overexpression predict poor prognosis in melanoma and squamous cell carcinoma patients.DSS1启动子低甲基化和过表达预示黑色素瘤和鳞状细胞癌患者预后不良。
Hum Pathol. 2017 Feb;60:137-146. doi: 10.1016/j.humpath.2016.10.018. Epub 2016 Nov 4.
10
Epigenetic regulation of microRNA genes and the role of miR-34b in cell invasion and motility in human melanoma.miRNA 基因的表观遗传调控及 miR-34b 在人黑色素瘤细胞侵袭和迁移中的作用
PLoS One. 2011;6(9):e24922. doi: 10.1371/journal.pone.0024922. Epub 2011 Sep 19.
引用本文的文献
1
Epigenetics in Skin Homeostasis and Ageing.皮肤稳态与衰老中的表观遗传学
Epigenomes. 2025 Jan 9;9(1):3. doi: 10.3390/epigenomes9010003.
2
The new era of immune skin diseases: Exploring advances in basic research and clinical translations.免疫性皮肤病的新时代：探索基础研究与临床转化的进展
J Transl Autoimmun. 2024 Jan 12;8:100232. doi: 10.1016/j.jtauto.2024.100232. eCollection 2024 Jun.
3
Transglutaminase 3 regulates cutaneous squamous carcinoma differentiation and inhibits progression via PI3K-AKT signaling pathway-mediated Keratin 14 degradation.转谷氨酰胺酶 3 通过调控 PI3K-AKT 信号通路介导的角蛋白 14 降解调控皮肤鳞状细胞癌分化并抑制其进展。
Cell Death Dis. 2024 Apr 8;15(4):252. doi: 10.1038/s41419-024-06626-5.
4
Upregulation and functional roles of miR-450b in canine oral melanoma.miR-450b在犬口腔黑色素瘤中的上调及其功能作用
Noncoding RNA Res. 2024 Feb 1;9(2):376-387. doi: 10.1016/j.ncrna.2024.01.017. eCollection 2024 Jun.
5
Phytochemicals as Immunomodulatory Agents in Melanoma.植物化学物质作为黑色素瘤的免疫调节剂。
Int J Mol Sci. 2023 Jan 31;24(3):2657. doi: 10.3390/ijms24032657.
6
Promising Blood-Based Biomarkers for Melanoma: Recent Progress of Liquid Biopsy and Its Future Perspectives.液体活检的最新进展及其未来展望：有望成为黑色素瘤的血液生物标志物。
Curr Treat Options Oncol. 2022 Apr;23(4):562-577. doi: 10.1007/s11864-022-00948-2. Epub 2022 Mar 17.
7
Recent Developments of Circulating Tumor Cell Analysis for Monitoring Cutaneous Melanoma Patients.用于监测皮肤黑色素瘤患者的循环肿瘤细胞分析的最新进展
Cancers (Basel). 2022 Feb 9;14(4):859. doi: 10.3390/cancers14040859.
8
UV Radiation and Its Relation to DNA Methylation in Epidermal Cells: A Review.紫外线辐射及其与表皮细胞中DNA甲基化的关系：综述
Epigenomes. 2020 Sep 30;4(4):23. doi: 10.3390/epigenomes4040023.
9
Acetylated DNMT1 Downregulation and Related Regulatory Factors Influence Metastatic Melanoma Patients Survival.乙酰化DNMT1下调及相关调控因子影响转移性黑色素瘤患者的生存。
Cancers (Basel). 2021 Sep 18;13(18):4691. doi: 10.3390/cancers13184691.
10
Characterizing DNA methylation signatures and their potential functional roles in Merkel cell carcinoma.描述 Merkel 细胞癌中 DNA 甲基化特征及其潜在的功能作用。
Genome Med. 2021 Aug 16;13(1):130. doi: 10.1186/s13073-021-00946-3.
本文引用的文献
1
Chromatin immunoprecipitation (ChIP): revisiting the efficacy of sample preparation, sonication, quantification of sheared DNA, and analysis via PCR.染色质免疫沉淀（ChIP）：重新审视样品制备、超声处理、剪切 DNA 定量和 PCR 分析的效果。
PLoS One. 2011;6(10):e26015. doi: 10.1371/journal.pone.0026015. Epub 2011 Oct 25.
2
A review of the epidemiology and treatment of Merkel cell carcinoma. Merkel 细胞癌的流行病学和治疗综述。
Clinics (Sao Paulo). 2011;66(10):1817-23. doi: 10.1590/s1807-59322011001000023.
3
Epigenetic regulation of microRNA genes and the role of miR-34b in cell invasion and motility in human melanoma.miRNA 基因的表观遗传调控及 miR-34b 在人黑色素瘤细胞侵袭和迁移中的作用
PLoS One. 2011;6(9):e24922. doi: 10.1371/journal.pone.0024922. Epub 2011 Sep 19.
4
Advances in epigenetic technology.表观遗传技术的进展。
Methods Mol Biol. 2011;791:1-10. doi: 10.1007/978-1-61779-316-5_1.
5
Underestimation of Gleason score at prostate biopsy reflects sampling error in lower volume tumours.前列腺穿刺活检时低估 Gleason 评分反映了低容量肿瘤中采样误差。
BJU Int. 2012 Mar;109(5):660-4. doi: 10.1111/j.1464-410X.2011.10543.x. Epub 2011 Sep 2.
6
miR-21 and miR-155 are associated with mitotic activity and lesion depth of borderline melanocytic lesions.miR-21 和 miR-155 与交界性黑色素瘤的有丝分裂活性和病变深度有关。
Br J Cancer. 2011 Sep 27;105(7):1023-9. doi: 10.1038/bjc.2011.288. Epub 2011 Aug 23.
7
A novel oncogenic role for the miRNA-506-514 cluster in initiating melanocyte transformation and promoting melanoma growth.miR-506-514 簇在启动黑素细胞转化和促进黑色素瘤生长中的新致癌作用。
Oncogene. 2012 Mar 22;31(12):1558-70. doi: 10.1038/onc.2011.345. Epub 2011 Aug 22.
8
miR-30b/30d regulation of GalNAc transferases enhances invasion and immunosuppression during metastasis.miR-30b/30d 调控半乳糖胺转移酶增强转移过程中的侵袭和免疫抑制。
Cancer Cell. 2011 Jul 12;20(1):104-18. doi: 10.1016/j.ccr.2011.05.027.
9
Epigenetic regulation of microRNA-375 and its role in melanoma development in humans.miRNA-375 的表观遗传调控及其在人类黑色素瘤发生中的作用。
FEBS Lett. 2011 Aug 4;585(15):2467-76. doi: 10.1016/j.febslet.2011.06.025. Epub 2011 Jun 26.
10
Analytical aspects of microRNA in diagnostics: a review.miRNA 在诊断学中的分析方面：综述
Anal Chim Acta. 2011 Aug 12;699(2):134-52. doi: 10.1016/j.aca.2011.05.025. Epub 2011 May 20.
Zotero 插件